Elena Fdez
Granada, AN 18016, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
A potential patient stratification biomarker for Parkinson´s disease based on LRRK2 kinase-mediated centrosomal alterations in peripheral blood-derived cells.
Journal: NPJ Parkinson's disease
Published: April 19, 2023
Iron-induced cytotoxicity mediated by endolysosomal TRPML1 channels is reverted by TFEB.
Journal: Cell death & disease
Published: October 19, 2022
The LRRK2 signaling network converges on a centriolar phospho-Rab10/RILPL1 complex to cause deficits in centrosome cohesion and cell polarization.
Journal: Biology open
Published: June 02, 2022
Evaluation of Current Methods to Detect Cellular Leucine-Rich Repeat Kinase 2 (LRRK2) Kinase Activity.
Journal: Journal of Parkinson's disease
Published: May 23, 2022
Pathogenic LRRK2 regulates centrosome cohesion via Rab10/RILPL1-mediated CDK5RAP2 displacement.
Journal: iScience
Published: August 24, 2021
RAB8, RAB10 and RILPL1 contribute to both LRRK2 kinase-mediated centrosomal cohesion and ciliogenesis deficits.
Journal: Human molecular genetics
Published: June 20, 2019
RAB7L1-Mediated Relocalization of LRRK2 to the Golgi Complex Causes Centrosomal Deficits via RAB8A.
Journal: Frontiers in molecular neuroscience
Published: August 26, 2018
Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation.
Parkinson disease-associated mutations in LRRK2 cause centrosomal defects via Rab8a phosphorylation.
Journal: Molecular neurodegeneration
Published: June 05, 2017
GTP binding regulates cellular localization of Parkinson's disease-associated LRRK2.
Journal: Human molecular genetics
Published: February 19, 2017
Last Updated: 09/26/2026